FA
MIRO

Friess Associates’s Miromatrix Medical Inc. Common Stock MIRO Stock Holding History

Friess Associates’s Portfolio MIRO Stock Details MIRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-246,323
Closed -$1.16M – 125
2021
Q4 		$1.16M Hold
246,323
– – 0.45% 72
2021
Q3 		$1.71M Buy
246,323
+26,323
+12% +$248K 0.72% 66
2021
Q2 		$2.56M Buy
+220,000
New +$2.83M 0.97% 42

Other funds holding MIRO

GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIMM
Stillwater Investment Management (Minnesota) Stillwater, Minnesota $372M AUM 5.45% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Friess Associates's MIRO Position: Q1 2022 in Review

Friess Associates sold out of Miromatrix Medical Inc. Common Stock (MIRO) in Q1 2022, closing a stake of 246,323 shares — an estimated $1.16M sold.

Friess Associates first reported a position in MIRO in Q2 2021 and held it in 3 quarters. The position peaked at $2.56M in Q2 2021. 21 funds tracked by Wall St. Rank hold MIRO as of Q1 2022.

  • Friess Associates reported no remaining Miromatrix Medical Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Friess Associates sold 246,323 Miromatrix Medical Inc. Common Stock shares in Q1 2022, an estimated $1.16M.
  • Friess Associates first reported a position in Miromatrix Medical Inc. Common Stock in Q2 2021 and held it in 3 quarters.
  • Friess Associates's Miromatrix Medical Inc. Common Stock position peaked at $2.56M in Q2 2021.
  • 21 funds tracked by Wall St. Rank held Miromatrix Medical Inc. Common Stock as of Q1 2022.

Based on Friess Associates's 13F filing for Q1 2022, filed 12 May 2022.